Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?

It’s only natural that many investors, especially those who are new to the game, prefer to buy shares in ‘sexy’ stocks with a good story, even if those businesses lose money. And in . found that it is ‘quite common’ for investors to lose money by buying into ‘pump and dump’ schemes.

In contrast to all that, I prefer to spend time on companies like China Traditional Chinese Medicine Holdings (HKG:570), which has not only revenues, but also profits. While that doesn’t make the shares worth buying at any price, you can’t deny that successful capitalism requires profit, eventually. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.

See our latest analysis for China Traditional Chinese Medicine Holdings

China Traditional Chinese Medicine Holdings’s Earnings Per Share Are Growing.

As one of my mentors once told me, share price follows earnings per share (EPS). It’s no surprise, then, that I like to invest in companies with EPS growth. It certainly is nice to see that China Traditional Chinese Medicine Holdings has managed to grow EPS by 26% per year over three years. As a general rule, we’d say that if a company can keep up that sort of growth, shareholders will be smiling.

I like to see top-line growth as an indication that growth is sustainable, and I look for a high earnings before interest and taxation (EBIT) margin to point to a competitive moat (though some companies with low margins also have moats). While China Traditional Chinese Medicine Holdings did well to grow revenue over the last year, EBIT margins were dampened at the same time. So if EBIT margins can stabilize, this top-line growth should pay off for shareholders.

In the chart below, you can see how the company has grown earnings, and revenue, over time. Click on the chart to see the exact numbers.

SEHK:570 Income Statement, April 19th 2019
SEHK:570 Income Statement, April 19th 2019

The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. To that end, right now and today, you can check our visualization of consensus analyst forecasts for future China Traditional Chinese Medicine Holdings EPS 100% free.

Are China Traditional Chinese Medicine Holdings Insiders Aligned With All Shareholders?

It makes me feel more secure owning shares in a company, if insiders also own shares, thusly more closely aligning our interests. As a result, I’m encouraged by the fact that insiders own China Traditional Chinese Medicine Holdings shares worth a considerable sum. Notably, they have an enormous stake in the company, worth CN¥2.5b. I would find that kind of skin in the game quite encouraging, if I owned shares, since it would ensure that the leaders of the company would also experience my success, or failure, with the stock.

It means a lot to see insiders invested in the business, but I find myself wondering if remuneration policies are shareholder friendly. Well, based on the CEO pay, I’d say they are indeed. I discovered that the median total compensation for the CEOs of companies like China Traditional Chinese Medicine Holdings with market caps between CN¥13b and CN¥43b is about CN¥3.0m.

The China Traditional Chinese Medicine Holdings CEO received CN¥2.0m in compensation for the year ending December 2017. That seems pretty reasonable, especially given its below the median for similar sized companies. CEO remuneration levels are not the most important metric for investors, but when the pay is modest, that does support enhanced alignment between the CEO and the ordinary shareholders. I’d also argue reasonable pay levels attest to good decision making more generally.

Does China Traditional Chinese Medicine Holdings Deserve A Spot On Your Watchlist?

For growth investors like me, China Traditional Chinese Medicine Holdings’s raw rate of earnings growth is a beacon in the night. If you need more convincing beyond that EPS growth rate, don’t forget about the reasonable remuneration and the high insider ownership. Each to their own, but I think all this makes China Traditional Chinese Medicine Holdings look rather interesting indeed. Now, you could try to make up your mind on China Traditional Chinese Medicine Holdings by focusing on just these factors, or you could also consider how its price-to-earnings ratio compares to other companies in its industry.

Of course, you can do well (sometimes) buying stocks that are not growing earnings and do not have insiders buying shares. But as a growth investor I always like to check out companies that do have those features. You can access a free list of them here.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.